123 related articles for article (PubMed ID: 24270191)
1. Evaluation of a low-cost liquid-based Pap test in rural El Salvador: a split-sample study.
Guo J; Cremer M; Maza M; Alfaro K; Felix JC
J Low Genit Tract Dis; 2014 Apr; 18(2):151-5. PubMed ID: 24270191
[TBL] [Abstract][Full Text] [Related]
2. Improved abnormal Pap smear triage using cervical cancer biomarkers.
Killeen JL; Dye T; Grace C; Hiraoka M
J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
Kaufman RH; Adam E; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
[TBL] [Abstract][Full Text] [Related]
4. Comparison of conventional and liquid-based Pap smear methods in the diagnosis of precancerous cervical lesions.
Honarvar Z; Zarisfi Z; Salari Sedigh S; Masoumi Shahrbabak M
J Obstet Gynaecol; 2022 Aug; 42(6):2320-2324. PubMed ID: 35579303
[TBL] [Abstract][Full Text] [Related]
5. Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer.
Upendram P; Sahni S; Mohiuddin K; Poornima S; Gourishankar B; Kumar Vattam K; Boddala P; Jayashankar E; Mohiuddin S; Kamineni V; Mohan V; Houldsworth J; Hasan Q
Tumour Biol; 2017 Oct; 39(10):1010428317698363. PubMed ID: 28990460
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
7. The PapSpin: a reasonable alternative to other, more expensive liquid-based Papanicolaou tests.
Rosenthal DL; Geddes S; Trimble CL; Carson KA; Alli PM
Cancer; 2006 Jun; 108(3):137-43. PubMed ID: 16628656
[TBL] [Abstract][Full Text] [Related]
8. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
9. Does the interval between papanicolaou tests influence the quality of cytology?
Jeronimo J; Khan MJ; Schiffman M; Solomon D;
Cancer; 2005 Jun; 105(3):133-8. PubMed ID: 15822121
[TBL] [Abstract][Full Text] [Related]
10. Applicability of On-Site Evaluation of Cervical Cytology Smears Stained with Toluidine Blue to Reduce Unsatisfactory Results.
Tummidi S; Shankaralingappa A; Sharmila V
Acta Cytol; 2022; 66(6):513-523. PubMed ID: 36215977
[TBL] [Abstract][Full Text] [Related]
11. Follow up of atypical squamous cell Pap smears in Iraqi women.
Pity IS; Shamdeen MY; Wais SA
Asian Pac J Cancer Prev; 2012; 13(7):3455-60. PubMed ID: 22994777
[TBL] [Abstract][Full Text] [Related]
12. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology versus conventional cytology for evaluation of cervical Pap smears: experience from the first 1000 split samples.
Singh VB; Gupta N; Nijhawan R; Srinivasan R; Suri V; Rajwanshi A
Indian J Pathol Microbiol; 2015; 58(1):17-21. PubMed ID: 25673585
[TBL] [Abstract][Full Text] [Related]
14. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
15. Digital holographic microscopy as screening tool for cervical cancer preliminary study.
Benzerdjeb N; Garbar C; Camparo P; Sevestre H
Cancer Cytopathol; 2016 Aug; 124(8):573-80. PubMed ID: 27136615
[TBL] [Abstract][Full Text] [Related]
16. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
Nasser SM; Cibas ES; Crum CP; Faquin WC
Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
[TBL] [Abstract][Full Text] [Related]
17. Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?
Lee NW; Kim D; Park JT; Kim A
Arch Pathol Lab Med; 2001 Nov; 125(11):1453-7. PubMed ID: 11698001
[TBL] [Abstract][Full Text] [Related]
18. Only a small fraction of high-grade cervical lesions are discovered after an interpretation of atypical squamous cells of undetermined significance when using imager-assisted, liquid-based papanicolaou tests and the Bethesda 2001 system.
Khan KA; Smith DA; Thrall MJ
Arch Pathol Lab Med; 2013 Jul; 137(7):936-41. PubMed ID: 22994456
[TBL] [Abstract][Full Text] [Related]
19. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
20. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
